Novartis AG is 57.8x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($282.64 B vs $4.89 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AMRX | NVS |
|---|---|---|
| Market cap | $4.89 B | $282.64 B |
| US-listed rank | #1397 | #47 |
| Revenue (latest FY) | $3.02B | - |
| Net income (latest FY) | $72.06M | - |
| Net margin | 2.4% | - |
| P/E (trailing FY) | 67.8 | - |
| SEC filings | 664 | 947 |
Novartis AG is 57.8x more valuable than Amneal Pharmaceuticals, Inc. by market capitalization ($282.64 B vs $4.89 B).
Full pages: Amneal Pharmaceuticals, Inc. and Novartis AG, or browse the full rankings.